| 1 |
Mild Cognitive Impairment
Ronald C. Petersen, Glenn E. Smith, Stephen C. Waring et al. · Archives of Neurology
|
Mar 1999 |
9,076 |
| 2 |
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
David F Cella, David S. Tulsky, Geoffrey V. Gray et al. · Journal of Clinical Oncology
|
Mar 1993 |
6,104 |
| 3 |
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
Kristin L. Campbell, Kerri M. Winters‐Stone, Joachim Wiskemann et al. · Medicine & Science in Sports & Exercise
Open access |
17 Oct 2019 |
3,064 |
| 4 |
Interpreting the significance of changes in health-related quality-of-life scores.
David Osoba, George Rodrigues, James D. Myles et al. · Journal of Clinical Oncology
|
1998 |
2,991 |
| 5 |
Cancer treatment and survivorship statistics, 2012
Rebecca L. Siegel, Carol E. Desantis, Katherine S. Virgo et al. · CA A Cancer Journal for Clinicians
Open access |
14 Jun 2012 |
2,959 |
| 6 |
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, Jeffrey Scott Andrews, Thomas G. Beach et al. · Alzheimer s & Dementia
Open access |
27 Jun 2024 |
2,670 |
| 7 |
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
Ethan Basch, Allison Mary Deal, Amylou Constance Dueck et al. · JAMA
Open access |
6 Jun 2017 |
2,373 |
| 8 |
Exercise builds brain health: key roles of growth factor cascades and inflammation
Carl W. Cotman, Nicole C. Berchtold, Lori‐Ann Christie · Trends in Neurosciences
Review |
Sep 2007 |
2,289 |
| 9 |
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
Sally Ann Shumaker, Claudine Legault, Stephen R. Rapp et al. · JAMA
|
27 May 2003 |
2,199 |
| 10 |
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
Marianne J. Brady, David F Cella, Fei Mo et al. · Journal of Clinical Oncology
|
Mar 1997 |
1,779 |
| 11 |
Donanemab in Early Alzheimer’s Disease
Mark A. Mintun, Albert Lo, Cynthia Duggan Evans et al. · New England Journal of Medicine
Open access |
13 Mar 2021 |
1,776 |
| 12 |
Cancer-related fatigue—mechanisms, risk factors, and treatments
Julienne E. Bower · Nature Reviews Clinical Oncology
ReviewOpen access |
12 Aug 2014 |
1,665 |
| 13 |
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten, Ellen A. A. Nollen, Ute F. Röhrig et al. · Nature Reviews Drug Discovery
ReviewOpen access |
13 Feb 2019 |
1,617 |
| 14 |
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress
Russell K. Portenoy, Howard T. Thaler, Alice B. Kornblith et al. · European Journal of Cancer
|
1994 |
1,597 |
| 15 |
Exercise Is Associated with Reduced Risk for Incident Dementia among Persons 65 Years of Age and Older
Eric B. Larson, Li Wang, James David Bowen et al. · Annals of Internal Medicine
|
17 Jan 2006 |
1,488 |
| 16 |
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Clifford R. Jack, Ronald Petersen, Yun Xu et al. · Neurology
Open access |
Apr 1999 |
1,418 |
| 17 |
Prevalence of Depression in Patients With Cancer
Mary Jane Massie · JNCI Monographs
Open access |
Jul 2004 |
1,417 |
| 18 |
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
Thomas K. Karikari et al. · The Lancet Neurology
Open access |
22 Apr 2020 |
1,411 |
| 19 |
Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women Women's Health Initiative Memory Study
Sally Ann Shumaker · JAMA
|
22 Jun 2004 |
1,370 |
| 20 |
An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis
Rebecca M. Speck, Kerry S. Courneya, Louise C. Mâsse et al. · Journal of Cancer Survivorship
Review |
5 Jan 2010 |
1,361 |
| 21 |
Participation in Cognitively Stimulating Activities and Risk of Incident Alzheimer Disease
Robert S. Wilson · JAMA
|
13 Feb 2002 |
1,344 |
| 22 |
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
Gregory A. Curt, WILLIAM S. BREITBART, David F Cella et al. · The Oncologist
|
Oct 2000 |
1,261 |
| 23 |
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Sébastien Simard, Belinda Thewes, Gerry M. Humphris et al. · Journal of Cancer Survivorship
Review |
9 Mar 2013 |
1,244 |
| 24 |
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Dawn L. Hershman, Christina Lacchetti, Robert H. Dworkin et al. · Journal of Clinical Oncology
Open access |
15 Apr 2014 |
1,233 |
| 25 |
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé et al. · Journal of Clinical Oncology
Open access |
28 Oct 2014 |
1,160 |
| 26 |
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score
Martine Extermann, I. Boler, Richard R. Reich et al. · Cancer
Open access |
9 Nov 2011 |
1,159 |
| 27 |
Fatigue in Breast Cancer Survivors: Occurrence, Correlates, and Impact on Quality of Life
Julienne E. Bower, Patricia A. Ganz, Katherine A. Desmond et al. · Journal of Clinical Oncology
|
14 Feb 2000 |
1,151 |
| 28 |
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Charles L. Loprinzi, Christina Lacchetti, Jonathan Scott Bleeker et al. · Journal of Clinical Oncology
Open access |
14 Jul 2020 |
1,132 |
| 29 |
Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival
Sandra E. Sephton · JNCI Journal of the National Cancer Institute
|
21 Jun 2000 |
1,103 |
| 30 |
Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis
Margaret L. McNeely · Canadian Medical Association Journal
ReviewOpen access |
4 Jul 2006 |
1,096 |
| 31 |
Exercise for the management of cancer-related fatigue in adults
Fiona L. Cramp, James Byron‐Daniel · Cochrane Database of Systematic Reviews
Open access |
8 Nov 2012 |
1,093 |
| 32 |
Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Tali Cukierman, Hertzel C. Gerstein, Jeff D. Williamson · Diabetologia
|
8 Nov 2005 |
1,062 |
| 33 |
Quality of Life in Long-Term, Disease-Free Survivors of Breast Cancer: a Follow-up Study
Peter Ganz · JNCI Journal of the National Cancer Institute
|
2 Jan 2002 |
1,059 |
| 34 |
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Amylou Constance Dueck et al. · JAMA Oncology
Open access |
13 Aug 2015 |
1,045 |
| 35 |
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
Jeffrey Scott Wefel, Janette L. Vardy, Tim A. Ahles et al. · The Lancet Oncology
|
26 Feb 2011 |
1,022 |
| 36 |
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
Kathryn A. Ellis, Ashley Ian Bush, David Darby et al. · International Psychogeriatrics
Open access |
27 May 2009 |
1,010 |
| 37 |
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
Ruth A. Mulnard, Carl W. Cotman, Claudia H. Kawas et al. · PubMed
Open access |
23 Feb 2000 |
996 |
| 38 |
Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials
Michael J Grundman · Archives of Neurology
|
2004 |
979 |
| 39 |
Anthracycline Chemotherapy and Cardiotoxicity
John McGowan, Robin Chung, Angshuman Maulik et al. · Cardiovascular Drugs and Therapy
Open access |
Feb 2017 |
972 |
| 40 |
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease
Claudia H. Kawas, Susan M. Resnick, Anthony D. Morrison et al. · Neurology
Open access |
Jun 1997 |
970 |
| 41 |
Cancer-Related Fatigue, Version 2.2015
Ann M. Berger et al. · Journal of the National Comprehensive Cancer Network
Open access |
Aug 2015 |
964 |
| 42 |
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
Paul David Brown, Shannon K. Pugh, Nadia N. Laack et al. · Neuro-Oncology
Open access |
16 Aug 2013 |
963 |
| 43 |
Management of Cancer in the Older Person: A Practical Approach
Lodovico Balducci, Martine Extermann · The Oncologist
|
Jun 2000 |
955 |
| 44 |
Radiation‐induced dementia in patients cured of brain metastases
Lisa Marie DeAngelis, Jean‐Yves Delattre, Jerome B. Posner · Neurology
|
Jun 1989 |
951 |
| 45 |
Estrogen Therapy in Postmenopausal Women
Kristine S. Yaffe, George F. Sawaya, Ivan M. Lieberburg et al. · JAMA
|
4 Mar 1998 |
949 |
| 46 |
High levels of untreated distress and fatigue in cancer patients
Linda Ellen Carlson, Maureen Angen, Jodi Cullum et al. · British Journal of Cancer
Open access |
25 May 2004 |
948 |
| 47 |
Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women
Stephen R. Rapp, Mark Andrew Espeland, Sally Ann Shumaker et al. · JAMA
|
27 May 2003 |
936 |
| 48 |
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
Karen Michelle Mustian, Catherine M. Alfano, Charles E. Heckler et al. · JAMA Oncology
Open access |
2 Mar 2017 |
927 |
| 49 |
Candidate mechanisms for chemotherapy-induced cognitive changes
Tim A. Ahles, Andrew J. Saykin · Nature reviews. Cancer
ReviewOpen access |
23 Feb 2007 |
925 |
| 50 |
Prevalence of depression in cancer patients: a meta‐analysis of diagnostic interviews and self‐report instruments
A.M.H. Krebber, Laurien M. Buffart, Gitta Kleijn et al. · Psycho-Oncology
Open access |
16 Sep 2013 |
920 |